What are the Factors Driving the Tinnitus Medical Devices Market?



DelveInsight's “Tinnitus Medical Devices Market” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Tinnitus Medical Devices companies actively working in the market.

What are Tinnitus Medical Devices?

Tinnitus medical devices can help people manage their disease by reducing the perceived intensity, omnipresence, and burden of their tinnitus. These tools are available in a variety of product kinds and offer a variety of capabilities to help with tinnitus. Wearable sound generators, tinnitus masking devices, hearing aids, tinnitus cure pillows, notched-music devices, and others are examples of many product categories.

DelveInsight Analysis: The Global Tinnitus Medical Devices market size was valued at USD  1855.18 million in the year 2021 and is anticipated to grow with a CAGR of 3.49% during the forecasted period (2022-2027)

Tinnitus Medical Devices Market Insights

Geographically, North America is anticipated to rule the global market for tinnitus medical devices from 2022 to 2027. During the forecast period of 2022–2027, the demand for the North American tinnitus medical devices market is anticipated to be driven by the rising prevalence of hearing disorders, escalating burden of the geriatric population, rising number of product launches, as well as rising number of government initiatives made for the safety, and wellbeing of the population's hearing healthcare.

What are the Recent Developments in the Tinnitus Medical Devices Market Report?

In August 2022, GN Hearing, a global leader in intelligent audio solutions, had announced the launch of ReSound OMNIA that provides significantly better hearing in noisy environments, with optimal comfort having a seamless connection to the devices. In May 2022, Neuromod Devices Ltd., develop and commercialize a treatment for chronic tinnitus, reached an agreement with HØR AS, Norway’s largest private provider of hearing and tinnitus care, to make its Lenire tinnitus treatment device available in Norway. In March 2022, Starkey, a privately held, global hearing technology company headquartered in Eden Prairie, Minnesota, announced that its newest and most advanced family of hearing aids, Evolv AI, is available for the people in the market. Thus, owing to such developments in the market, rapid growth will be observed in the Tinnitus Medical Devices market during the forecast period

To read more about the latest highlights related to Tinnitus Medical Devices, get a snapshot of the key highlights entailed in the Tinnitus Medical Devices Market Report

Which are the key companies in the Tinnitus Medical Devices Market?

Some of the key companies in the Tinnitus Medical Devices market include-  Starkey Laboratories, Inc., Neuromod, Neuromonics, Demant A/S, Puretone Ltd., GN Store Nord A/S, WS Audiology A/S, Sonova, MDHearing, Elkon Pvt. Ltd., Audina Hearing Instruments, Inc., Arphi Electronics Private Limited, Foshan Vohom Technology Co., Ltd., KIND GmbH & Co. KG, RION Co., Ltd., Istok Audio Trading LLC, Eargo Inc., AlgorKorea Co., Ltd., Lisound Hearing Aid (Fuzhou) Co., Ltd., Guangzhou Melison Medical Instrument Co., Ltd., and others.

What is the impact of COVID-19 on the Tinnitus Medical Devices Market?

The market for tinnitus medical devices has been slightly influenced by the COVID-19 epidemic. During the pandemic, ENT departments, ENT clinics, audiology centers, and other facilities were closed in order to prevent the spread of the disease among patients and hospital staff. The outbreak of the pandemic caused the cancellation of outpatient visits and the suspension of non-emergency hospitals. Additionally, production of the gadgets was delayed due to a shortage of resources and labor.

Scope of the Tinnitus Medical Devices Market Report

  • Coverage: Global

  • Study Period: 2019–2027

  • Tinnitus Medical Devices Market Segmentation By Product Type: (Sound Masking Devices,  Notched- Music Devices, Hearing Aids), and others

  • Tinnitus Medical Devices Market Segmentation By Distribution Channels: (Hospital And Retail Pharmacy, Specialty Clinics), and others

  • Tinnitus Medical Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World

  • Key Tinnitus Medical Devices Companies: Starkey Laboratories, Inc., Neuromod, Neuromonics, Demant A/S, Puretone Ltd., GN Store Nord A/S, WS Audiology A/S, Sonova, MDHearing, Elkon Pvt. Ltd., Audina Hearing Instruments, Inc., Arphi Electronics Private Limited, Foshan Vohom Technology Co., Ltd., KIND GmbH & Co. KG, RION Co., Ltd., Istok Audio Trading LLC, Eargo Inc., AlgorKorea Co., Ltd., Lisound Hearing Aid (Fuzhou) Co., Ltd., Guangzhou Melison Medical Instrument Co., Ltd., among others

  • Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Interested in knowing how the Tinnitus Medical Devices market will grow by 2027? Click to get a snapshot of the Tinnitus Medical Devices Market Analysis

Comments

Post a Comment

Popular posts from this blog

Raising the Bar: ADCs and Lung Cancer Treatment Breakthroughs

Image
  The ENHERTU Effect: A Closer Look at the Dynamic Duo Daiichi Sankyo and AstraZeneca Taking on HER2-mutant NSCLC Lung cancer remains one of the most challenging and prevalent forms of cancer. Within this landscape, innovative treatments are offering new hope. One such breakthrough is the collaboration between Daiichi Sankyo and AstraZeneca, which brings forth ENHERTU, an Antibody-Drug Conjugate (ADC). ENHERTU is making strides in targeting HER2-mutant Non-Small Cell Lung Cancer (NSCLC), a rare and challenging subset of the disease. The ENHERTU partnership aims to address this unmet medical need with a highly targeted approach. Dato-DXd vs. TRODELVY: The Battle of ADC Targeting TROP2 As the world of ADCs expands, another remarkable battle is brewing between Daiichi Sankyo's Dato-DXd and TRODELVY in their quest to target TROP2. TROP2, also known as CEACAM5, is an antigen overexpressed in various cancers, including endometrial cancer. Both ADCs hold the potential to transform the
Read more
Image
Covering the Therapeutic Advancements in Obstructive Sleep Apnea Treatment Scenario Obstructive Sleep Apnea (OSA) is a common chronic sleep disorder, which is characterized by periodic narrowing and obstruction of the pharyngeal airway during sleep, leading to a complete or partial obstruction of the airway, results of which are apneas, hypopneas, or sometimes both. Obstructive sleep apnea is a chronic and permanent condition, through proper therapy and medications the condition can be cured. Almost every system in the body is affected by Obstructive Sleep Apnea, resulting in an increased incidence of hypertension, stroke, altered immune system, and cardiovascular disease.  Obstructive Sleep Apnea is caused when the throat muscles relax during sleep, which causes the tissue in the back of the throat to collapse and block the upper airway. Daytime sleepiness is one of the most common symptoms of Obstructive Sleep Apnea. People affected with Obstructive Apnea also complain of memory pro
Read more

Market Drivers and Barriers for Vascular Stents: An In-Depth Analysis

Image
  What are Vascular Stents? Vascular stents are medical devices that are used to treat narrow or blocked blood vessels. They are small, mesh-like tubes that are inserted into the affected artery to help prop it open and improve blood flow. The global vascular stents market is expected to grow significantly in the coming years due to an increase in the prevalence of cardiovascular diseases, technological advancements in stent design, and the growing aging population. Vascular Stents Market Size and Forecast The global vascular stents market size is expected to reach USD 16.52 billion by 2028, growing at a CAGR of 6.7% from 2021 to 2028. North America dominates the market due to a high prevalence of cardiovascular diseases, increased healthcare spending, and better healthcare infrastructure. Vascular Stents Market Trends and Analysis The market is experiencing a shift towards the development of bioresorbable stents that dissolve within the body after the artery has healed. This reduces
Read more